Baker McKenzie advised GlaxoSmithKline on the deal. GlaxoSmithKline (GSK) executed a AUD 106 million sale and lease back of its manufacturing facility at Boronia in Melbourne...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Clarus Corporation on the transaction. Clarus Corporation completed the acquisition of Rhino-Rack, an Australian based, leading aftermarket automotive roof rack and accessories brand....
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Apposite on the transaction. Niederer Kraft Frey advised Credit Suisse. Apposite Capital LLP completed the acquisition of 1MED SA, a Swiss firm specialising in...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Amtel Properties on the transaction, Aequo advised Dragon Capital on the deal. Amtel Properties completed the sale of its office and logistics complex “Amtel”...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised the shareholders of Heinenoord in this transaction and De Brauw Blackstone Westbroek advised NN Group. NN Group completed the acquisition of 70% of...
You must be a Standard 1 Year member to access this content.
Baker McKenzie acted as legal advisor to the Joint Bookrunners. Gernandt & Danielsson has advised Sinch. Sinch has carried out a primary issuance of shares of...
You must be a Standard 1 Year member to access this content.
Baker McKenzie and EBN Law advised Yum! Brands Inc. on the acquisition of Dragontail Systems Limited, assisted by Thomson Geer. Yum! Brands Inc. announced the acquisition of...
You must be a Standard 1 Year member to access this content.
Baker McKenzie Wong & Leow advised Zuellig Pharma on the deal. Zuellig Pharma’s Singapore subsidiary MiCare HealthTEC Holdings Pte. Ltd. executed a strategic M&A transaction pursuant to which...
You must be a Standard 1 Year member to access this content.
Baker McKenzie Wong & Leow advised Zuellig Pharma on the deal. Zuellig Pharma’s Singapore subsidiary MiCare HealthTEC Holdings Pte. Ltd. executed a strategic M&A transaction pursuant to which...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Numab Therapeutics on the deal. Numab Therapeutics closed a CHF 100 million (approximately USD 110 million) Series C financing. Numab Therapeutics is a clinical...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised China Evergrande Group on the deal. China Evergrande Group, a company listed on the Hong Kong Stock Exchange executed the disposal of 2.66% of...
You must be a Standard 1 Year member to access this content.
Baker McKenzie and Ropes & Gray advised Aurora Acquisition Corp. on the transaction, while Fried Frank acted as counsel to BofA Securities as financial advisor. Sullivan...
You must be a Standard 1 Year member to access this content.
